SCHEMBL392299

SCHEMBL392299

O=C(O)CNC(=O)OCOC(=O)C1CCC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.38
KMT2A Q03164 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HTT P42858 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ALDH1A1 P00352 5/20 0.36
HPGD P15428 1/20 0.36
MEN1 O00255 1/20 0.35
TSHR P16473 1/20 0.35
MAPT P10636 1/20 0.35
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
ADRB3 P13945 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
PAX8 Q06710 1/20 0.33
BCHE P06276 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL390786 0.97 ADRB2 (0.37) ATMKMT2ASMN1; SMN2HTTTDP1
SCHEMBL392016 0.95 ALDH1A1 (0.38) ATMKMT2ASMN1; SMN2ALDH1A1MEN1
SCHEMBL393503 0.93 ALDH1A1 (0.37) ATMKMT2ASMN1; SMN2ALDH1A1HPGD
SCHEMBL1885005 0.81 ALDH1A1 (0.37) KMT2ASMN1; SMN2ALDH1A1MEN1TSHR
SCHEMBL18816752 0.75 ALDH1A1 (0.38) KMT2ASMN1; SMN2ALDH1A1MEN1MAPT
SCHEMBL390378 0.75 LMNA (0.39) KMT2AALDH1A1HPGDMEN1L3MBTL1
SCHEMBL3887942 0.75 ALDH1A1 (0.33) KMT2ASMN1; SMN2ALDH1A1MEN1TSHR
SCHEMBL393242 0.74 LMNA (0.41) KMT2ATDP1ALDH1A1HPGDL3MBTL1
SCHEMBL1883879 0.74 ALDH1A1 (0.37) KMT2ASMN1; SMN2ALDH1A1MEN1TSHR
SCHEMBL18792727 0.74 ALDH1A1 (0.40) KMT2ASMN1; SMN2ALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101590-B2 9-aminocarbonylsubstituted derivatives of glycylcyclines WYETH LLC (US) 2012-01-24 US disclosed
US-20070049564-A1 9-Aminocarbonylsubstituted derivatives of glycylcyclines WYETH (US) 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049564-A1 9-Aminocarbonylsubstituted derivatives of glycylcyclines Q6ZSR9, GMPS, RPS10 ATM 3806/4885KMT2A 2161/4885SMN1; SMN2 4211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.